Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Clinical trial NCT04611321 · TERMINATED
Trial details
- NCT number
- NCT04611321
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-03-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.